Biotech, healthcare and health-tech startups, from drug discovery to care delivery. In the last 12 months Value Add VC tracked 143 venture rounds in Health & Biotech totaling $12.0B across 135 companies, with a median round of $50M. The last three months saw 87 rounds and $7.6B, ahead of the 12-month pace.
| Rounds tracked | Last 3 months | Last 6 months | Last 12 months |
|---|---|---|---|
| Rounds | 87 | 134 | 143 |
| Dollars | $7.6B | $11.3B | $12.0B |
| Companies | 85 | 128 | 135 |
| Median round | $58M | $54M | $50M |
Rounds tracked by Value Add VC from filings, wire releases and news outlets, not a total for the whole market. Private companies only.
Value Add VC intelligence database (rounds tracked from filings, wires and outlets)
| Item | Value |
|---|---|
| Dec 25 | $180M · 2 rounds |
| Jan 26 | $0M · 0 rounds |
| Feb 26 | $0M · 0 rounds |
| Mar 26 | $200M · 2 rounds |
| Apr 26 | $5M · 1 rounds |
| May 26 | $299M · 9 rounds |
| Jun 26 | $1.2B · 17 rounds |
| Jul 26 | $2.1B · 20 rounds |
| Aug 26 | $937M · 16 rounds |
| Sep 26 | $3.4B · 27 rounds |
| Oct 26 | $3.2B · 45 rounds |
| Nov 26 | $85M · 2 rounds |
Value Add VC intelligence database (rounds tracked from filings, wires and outlets)
| Item | Value |
|---|---|
| Dec 25 | 2 |
| Jan 26 | 0 |
| Feb 26 | 0 |
| Mar 26 | 2 |
| Apr 26 | 1 |
| May 26 | 9 |
| Jun 26 | 17 |
| Jul 26 | 20 |
| Aug 26 | 16 |
| Sep 26 | 27 |
| Oct 26 | 45 |
| Nov 26 | 2 |
Value Add VC intelligence database (rounds tracked from filings, wires and outlets)
| Item | Value |
|---|---|
| Undisclosed | 57 rounds · $3.1B |
| Series B | 23 rounds · $2.3B |
| Series A | 22 rounds · $1.0B |
| Series D+ / growth | 20 rounds · $2.3B |
| Series C | 17 rounds · $3.2B |
| Seed | 4 rounds · $68M |
| Date | Company | Stage | Amount | Led by |
|---|---|---|---|---|
| Jul 15, 2026 | Neko Health | Series C | $700M | Lightspeed Venture Partners, OG Venture Partners |
| Jul 14, 2026 | Chai Discovery | Series C | $400M | Index Ventures |
| Oct 30, 2026 | Dren Bio | — | $350M | Lightspeed Venture Partners |
| Sep 22, 2026 | Heidi Health | Series C | $340M | Blackbird Ventures |
| Jun 25, 2026 | Ollin Biosciences | Series B | $330M | TCG Crossover |
| Sep 23, 2026 | Enveda Biosciences | Series E | $311M | Catalio Capital Management |
| Oct 15, 2026 | OMass Therapeutics | Series C | $310M | Bain Capital Life Sciences, Forbion |
| Nov 19, 2025 | Function Health | Series B | $298M | Redpoint Ventures |
| Sep 16, 2026 | Anew Labs | — | $290M | HongShan (Sequoia China) |
| Sep 9, 2026 | Encoded Therapeutics | Series F | $275M | Google Ventures (GV) |
| Date | Company | Stage | Amount | Led by |
|---|---|---|---|---|
| Nov 5, 2026 | Brij Medical | — | $5M | — |
| Nov 3, 2026 | Lyell Immunopharma | — | $80M | — |
| Oct 30, 2026 | Dren Bio | — | $350M | Lightspeed Venture Partners |
| Oct 30, 2026 | GoodMood Holdings | Growth | $45M | — |
| Oct 30, 2026 | Midstream Health | Series A | $20M | — |
| Oct 30, 2026 | Setara Biosciences | Series A | $90M | — |
| Oct 30, 2026 | Stairmed | late-stage | $192.5M | — |
| Oct 30, 2026 | StimCardio Medical | Series A | $30M | — |
| Oct 30, 2026 | Wrapped Health | Pre-seed | $2.1M | Lightbank |
| Oct 28, 2026 | Blue Arbor Technologies | Series A | $10.5M | — |
| Oct 28, 2026 | ClarityCare | Series A | $16.5M | Headline |
| Oct 28, 2026 | Coherence Neuro | Series A | $45M | Founders Fund |